Marko Lucijanic: The ZEBRA Score A New Tool for Predicting Thrombotic Risk in Myelofibrosis
Marko Lucijanic, Head of Scientific Research and Translational Medicine Department at University Hospital Dubrava, Zagreb, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Thrombosis Research, adding:
“We are very proud that our ZEBRA score, describing thrombotic risk in patients with myelofibrosis, has been published in the renowned Thrombosis Research journal.
This simple score may help identify MF patients at the highest risk of thrombosis, a dimension of risk that often goes unrecognized in current clinical practice.
Many thanks to all co-authors and collaborating centres who made this work possible.”
Title: ZEBRA score, a novel specialized prognostic model for thrombotic risk in myelofibrosis
Authors: Marko Lucijanic, Davor Galusic, Vlatka Perisa, Ivan Zekanovic, Martina Moric Peric, Hrvoje Holik, Rajko Kusec, Ivan Krecak

Stay updated with Hemostatis Today.
-
Nov 22, 2026, 12:58Saiyed raza Abbas: Understanding White Blood Cell Development and Maturation in Peripheral Blood Smears
-
Nov 22, 2026, 12:46Rui Providência: Anticoagulation After AF Ablation A Timely Discussion
-
Nov 22, 2026, 12:41Teresa Gerardi: KIT Inhibition with Avapritinib and Its Potential Impact on Mastocytosis-Related Osteoporosis
-
Nov 22, 2026, 12:37Rahul Bhargava: 2026 Haematology’s Shift From Chemotherapy to Immunotherapy
-
Nov 22, 2026, 12:27Saleh Shamse Basha: Can a Platelet Count Be Trusted After Accidental Centrifugation of a Citrate Tube?
-
Nov 22, 2026, 12:19Sophia Delicou: Transforming Haemoglobin Disorders Through Innovation and Patient-Centred Care
-
Nov 22, 2026, 12:15Toby Richards: Adenomyosis and Its Impact on Female Fertility
-
Nov 22, 2026, 11:11George Kumar: Early Gastric Cancer Detection Through Red Blood Cell DNA Profiling
-
Nov 22, 2026, 10:50Kemal Karaagac: A Phenotype-Guided Approach to Stroke Prevention